Medicare Enrolled
Dr. Sherry Rotunda, M.D.
MOHS-Micrographic Surgery Physician · Oceanside, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rotunda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rotunda?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rotunda
Dr. Sherry Rotunda is a mohs-micrographic surgery physician in Oceanside, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rotunda performed 5,939 Medicare services across 2,973 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rotunda received a total of $5,390 from 34 pharmaceutical and/or device companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rotunda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 29% volume in CA
$5,390 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,939
Medicare services
Top 29% in CA for mohs-micrographic surgery physician
2,973
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~313 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,311 | $6 | $22 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
757 | $68 | $281 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
683 | $43 | $214 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
522 | $98 | $394 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
345 | $78 | $331 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
240 | $98 | $368 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
206 | $510 | $2,180 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
124 | $41 | $176 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
117 | $45 | $164 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 103 | $376 | $1,332 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
93 | $238 | $1,502 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
84 | $256 | $1,378 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
47 | $111 | $790 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
47 | $143 | $537 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
40 | $1 | $3 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
38 | $550 | $2,051 |
| Skin graft repair of eyelid, nose, ear, or lip, 10 sq cm or less A surgical procedure to repair a wound on the eyelid, nose, ear, or lip by transferring a small piece of skin. The transferred skin covers an area of 10 square centimeters or less. |
32 | $661 | $2,518 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
28 | $36 | $179 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
25 | $355 | $1,292 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
17 | $110 | $440 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
16 | $126 | $880 |
| Skin graft repair, 10 sq cm or less A surgical procedure to repair a wound by transferring a small piece of skin to the affected area. The graft covers wounds on the face, neck, hands, feet, or other specified body parts. |
15 | $675 | $2,526 |
| Additional Mohs surgery stage with microscopic exam This procedure involves the removal and microscopic examination of an additional stage of tissue from the trunk, arms, or legs. It is performed in stages to ensure complete removal of the growth. |
15 | $361 | $1,259 |
| Complex wound repair, 1.1-2.5 cm A surgical procedure to close a complex wound measuring between 1.1 and 2.5 centimeters on areas such as the face, neck, hands, or feet. |
12 | $190 | $1,250 |
| Complex repair of eyelid, nose, ear, or lip wound, 1.1-2.5 cm A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 1.1 and 2.5 centimeters. |
11 | $191 | $1,348 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
11 | $68 | $310 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
9.4% medium
90.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,390
Total received (2018-2024)
Avg $770/year across 7 years
Top 27% in CA for mohs-micrographic surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
254
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,287 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$104 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,313
2023
$1,167
2022
$806
2021
$688
2020
$161
2019
$719
2018
$536
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$239
LEO Pharma Inc.
$211
UCB, Inc.
$199
E.R. Squibb & Sons, L.L.C.
$158
Janssen Biotech, Inc.
$104
REVANCE THERAPEUTICS, INC.
$96
PFIZER INC.
$77
SUN PHARMACEUTICAL INDUSTRIES INC.
$49
Novartis Pharmaceuticals Corporation
$39
Biofrontera Inc.
$30
Incyte Corporation
$26
Amgen Inc.
$18
Almirall LLC
$18
Galderma Laboratories, L.P.
$18
Arcutis Biotherapeutics, Inc.
$17
GENZYME CORPORATION
$13
Top 3 companies account for 49.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$658
LEO Pharma Inc.
$523
ABBVIE INC.
$502
AbbVie Inc.
$388
E.R. Squibb & Sons, L.L.C.
$343
PFIZER INC.
$321
Regeneron Healthcare Solutions, Inc.
$269
Sun Pharmaceutical Industries Inc.
$265
UCB, Inc.
$258
Biofrontera Inc.
$247
Novartis Pharmaceuticals Corporation
$229
Galderma Laboratories, L.P.
$172
GENZYME CORPORATION
$170
AbbVie, Inc.
$124
SUN PHARMACEUTICAL INDUSTRIES INC.
$119
Janssen Scientific Affairs, LLC
$119
REVANCE THERAPEUTICS, INC.
$96
Amgen Inc.
$81
Celgene Corporation
$72
Arcutis Biotherapeutics, Inc.
$49
Incyte Corporation
$43
DERMIRA, INC.
$42
Helsinn Therapeutics (U.S.), Inc.
$41
Almirall LLC
$38
Lilly USA, LLC
$34
Taro Pharmaceuticals USA, Inc.
$29
Krystal Biotech Inc
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Kyowa Kirin, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$19
Sientra, Inc.
$18
Mission Pharmacal Company
$17
STRATA Skin Sciences, Inc.
$17
Ortho Dermatologics, a division of Bausch Health US, LLC
$15
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ADBRY · AKLIEF · AMELUZ · Ameluz · Avar · Bimzelx · COSENTYX · Cimzia · DAXXIFY · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · HUMIRA · Humira · ILUMYA · Ilumya · Klisyri · LIBTAYO · OPZELURA · Otezla · POTELIGEO · QBREXZA · REMICADE · RETIN-A-MICRO · RINVOQ · SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT · SKYRIZI · SPEVIGO · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · VALCHLOR · VYJUVEK · Winlevi · XTRAC · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Mohs-micrographic surgery physicians within 10 mi
15
Per 100K population
0.5
County median income
$102,285
Nearest hospital
TRI-CITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rotunda is a clinical cardiology specialist, with above-average Medicare volume (top 29% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rotunda experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Rotunda performed 2,311 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rotunda receive payments from pharmaceutical companies?
Yes. Dr. Rotunda received a total of $5,390 from 34 companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rotunda's costs compare to other mohs-micrographic surgery physicians in Oceanside?
Dr. Rotunda's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rotunda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Mohs-Micrographic Surgery Physicians in Oceanside
Browse mohs-micrographic surgery physicians in Oceanside ranked by procedure volume and transparency data.
Highest volume
Top Mohs-Micrographic Surgery Physicians in CA
Mohs-micrographic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Mohs-Micrographic Surgery Physicians in CA
Which CA mohs-micrographic surgery physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
LEO Pharma Inc. Payments to Doctors
See all physicians who received payments from LEO Pharma Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology